| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/24/1991 | DE3923797A1 9-fluor-prostaglandin-derivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung 9-fluoro-prostaglandin derivatives, to processes for their preparation and their pharmaceutical use |
| 01/24/1991 | DE3923689A1 Neue verwendung von tetrahydrobenzthiazolderivaten als arzneistoffe New use of tetrahydrobenzthiazolderivaten as medicinal substances |
| 01/24/1991 | DE3923088A1 Combination anti-rheumatic compsns. - contg. dapson and non-steroidal antiinflammatory agent |
| 01/24/1991 | CA2063378A1 Androgen derivatives for use in the inhibition of sex steroid activity |
| 01/23/1991 | WO1991001297A1 2-amino-7-carbamoyl-1,2,3,4-tetrahydronaphthalenes, process for preparing them and their use as drugs |
| 01/23/1991 | EP0409812A2 Fucosidase inhibitor |
| 01/23/1991 | EP0409741A2 Hydrophilic porous material sterilizable with gamma-ray |
| 01/23/1991 | EP0409729A1 Bi-aromatic thioesters, process for their preparation and their use in human or veterinary medicine and in cosmetics |
| 01/23/1991 | EP0409728A2 Bi-aromatic esters, process for their preparation and their use in human or animal medicine and in cosmetics |
| 01/23/1991 | EP0409692A2 2 Imino-3 heterocyclylamino benzothiazoline, their preparation and medicine containing them |
| 01/23/1991 | EP0409690A1 Skinproducts with cosmetic and/or therapeutic effects |
| 01/23/1991 | EP0409676A1 Novel acetylcholinesterase inhibitors |
| 01/23/1991 | EP0409654A2 Liver function improver |
| 01/23/1991 | EP0409651A1 New Process for the preparation of anti-hypertensive benzopyran derivative |
| 01/23/1991 | EP0409575A1 Antiviral pyrimidine nucleosides |
| 01/23/1991 | EP0409559A2 Pharmaceutical uses of fatty acids |
| 01/23/1991 | EP0409528A2 Platinum triamine antitumor agents containing substituted anilines |
| 01/23/1991 | EP0409527A2 Cis-diamineplatinum complexes with methanediphosphonate and substituted methanediphosphonate ligands as antitumor agents |
| 01/23/1991 | EP0409499A2 Pharmaceutical compositions |
| 01/23/1991 | EP0409494A2 Stabilized composition of phytic acid |
| 01/23/1991 | EP0409490A1 Method of treatment |
| 01/23/1991 | EP0409489A2 Pharmaceuticals |
| 01/23/1991 | EP0409484A2 4,5,6,7-Tetrasubstituted benzoxazolones |
| 01/23/1991 | EP0409473A2 A process for obtaining the gangliosides from nervous tissue of mammalians and for the treatment of psychoorganic diseases with said material compositons |
| 01/23/1991 | EP0409435A1 Heteroaryl piperazine antipsychotic agents |
| 01/23/1991 | EP0409432A2 Confectionery delivery system |
| 01/23/1991 | EP0409414A1 Diaryl ether cycloalkanes |
| 01/23/1991 | EP0409413A2 Diaryl ether heterocycles |
| 01/23/1991 | EP0409412A2 Diaryl ether cyclic ethers |
| 01/23/1991 | EP0409410A1 Indenoindole compounds |
| 01/23/1991 | EP0409406A2 Aryl-substituted amine derivatives useful in cancer therapy |
| 01/23/1991 | EP0409392A2 Compositions and method for treatment of mast cell-mediated dermatologic disorders using nalmefene |
| 01/23/1991 | EP0409383A2 Estradiol compositions and methods for topical applications |
| 01/23/1991 | EP0409382A1 Glutamic acid derivatives |
| 01/23/1991 | EP0409332A2 Substituted triazoles as angiotensin II antagonists |
| 01/23/1991 | EP0409297A2 Steroid ethers |
| 01/23/1991 | EP0409296A2 Cardanolactam derivatives |
| 01/23/1991 | EP0409281A1 (R-(R*R*))-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl-3-phenyl-4((phenylamino)-carbonyl)-1H-pyrrole-1-heptanoic acid, its lactone form and salts thereof |
| 01/23/1991 | EP0409273A2 Substituted isoxazole and isothiazole derivatives |
| 01/23/1991 | EP0409236A1 Optically active naphthylethanol derivative |
| 01/23/1991 | EP0409227A2 Pyrimidine nucleosides, their preparation and pharmaceutical preparations |
| 01/23/1991 | EP0409223A2 3,4-Di-(hydro)-2H,6H-pyrimido[2,1-b][1,3]thiazine derivatives and 1,2,3,4-tetra-(hydro)-pyrimidin-2-thiones, process for their preparation and medicament containing them |
| 01/23/1991 | EP0409181A2 Phosphorus-containing squalene synthetase inhibitors and method for their preparation |
| 01/23/1991 | EP0409164A2 Phenacylpyridiniothiocephalosporins |
| 01/23/1991 | EP0409163A2 Novel cyclic vinylogous N-hydroxy-N-methylureas useful as 5-lipoxygenase inhibitors |
| 01/23/1991 | EP0409148A2 Improving cheese production |
| 01/23/1991 | EP0409125A1 Salts of N5, N10-methylene-5,6,7,8-tetrahydrofolic acid |
| 01/23/1991 | EP0409119A1 N,N'-Bis(alkoxy-alkyl)-pyridine-2,4-dicarboxylic acid amides, process for their preparation as well as their use |
| 01/23/1991 | EP0409081A1 Beta-Lactam Derivatives |
| 01/23/1991 | EP0409076A2 Saccharide copolymers having antibacterial activity |
| 01/23/1991 | EP0409055A1 Cephalosporin derivatives and processes for their preparation |
| 01/23/1991 | EP0409048A2 Aminoalkyl substituted 2-aminothiazoles and medicines containing them |
| 01/23/1991 | EP0409027A1 Indole derivatives, process for their preparation and their use in pharmaceuticals |
| 01/23/1991 | EP0408879A2 1-Substituted-2-(3-amino-1-propynyl)-pyrrolidine derivatives |
| 01/23/1991 | EP0408782A1 Antihypoxic agent |
| 01/23/1991 | EP0408749A1 Derivatives of 3,18-dihydroxy-9,13-epoxylabdane, method of obtaining them and a hemostatic pharmaceutical preparation based thereon |
| 01/23/1991 | EP0408731A1 Crosslinked hyaluronate gels, their use and method for producing them |
| 01/23/1991 | EP0408727A1 Glycosyl phospholipid nucleoside derivatives and their application as drugs |
| 01/23/1991 | EP0408674A1 Alternative energy substrate |
| 01/23/1991 | EP0408650A1 Method and composition for treating neurological disorders |
| 01/23/1991 | EP0259383B1 Pharmaceutical preparation and process for preparing the same |
| 01/23/1991 | CN1048706A 3-substituted vinyl cephalosporin derivatives and process for preparing same |
| 01/23/1991 | CN1048704A Pharmaceutical composition containing acrylic acid derivatives and application in medicine |
| 01/23/1991 | CN1048703A Acrylic amide, process for preparing same pharmaceutical preparation containing same and application in medicine tion in medicine |
| 01/23/1991 | CN1048659A Process for preparing hydrogel preparation and dry gel preparation |
| 01/23/1991 | CN1048656A Process for preparing polyisoprenyl compound having high content for soft capsules |
| 01/23/1991 | CN1011311B Process for preparing 1h-indol-3-yl containing 1,3 dimethyl-1h-purine-2,-6-diones |
| 01/23/1991 | CN1011289B In-vial deposition of 7-(dimethyl-aminomethylene) amino-9alpha-methoxymitosane |
| 01/23/1991 | CN1011287B Oral hygiene composition |
| 01/23/1991 | CA2033323A1 2-amino-7-carbamoyl-1,2,3,4-tetrahydronaphthalenes, processes for their preparation and their use as medicaments |
| 01/22/1991 | US4987246 Antitumor agents |
| 01/22/1991 | US4987231 Optical resolution method for 3R-(3-carboxybenzyl)-6-(5-fluoro-2-benzothiazolyl)methoxy-4R-chromanol |
| 01/22/1991 | US4987154 Biocompatible, stable and concentrated fluorocarbon emulsions for contrast enhancement and oxygen transport in internal animal use |
| 01/22/1991 | US4987153 Antiedemic, antiinflammatory |
| 01/22/1991 | US4987152 Use of sulfamoyl-substituted phenethylamine derivatives in treatment of lower urinary tract dysfunction |
| 01/22/1991 | US4987150 Hydroxyxanthones |
| 01/22/1991 | US4987147 Low toxicity |
| 01/22/1991 | US4987146 N-hetaryl imidazole derivatives |
| 01/22/1991 | US4987144 1,3-bis(1,2,4-triazol-1-yl)2-(4-trifluoromethylphenyl)propan-2-ol useful for the prevention and/or treatment of deep-seated mycosis |
| 01/22/1991 | US4987140 Antiinflammatory, antirheumatic |
| 01/22/1991 | US4987138 Hypotensives |
| 01/22/1991 | US4987137 Cerebral senility |
| 01/22/1991 | US4987136 Opioid antagonists |
| 01/22/1991 | US4987135 Leukemia, melanoma |
| 01/22/1991 | US4987134 Disorders of brain functions |
| 01/22/1991 | US4987133 Salicylic acid derivatives |
| 01/22/1991 | US4987131 4H-triazolo[4,3-a][1,4]benzodiazepines |
| 01/22/1991 | US4987130 Substituted amine derivatives, their production and use |
| 01/22/1991 | US4987128 Novel 10β-alkynyl-steroids |
| 01/22/1991 | US4987127 Method of treating a virus outbreak |
| 01/22/1991 | US4987126 Antitumor agents of daunorubicin type |
| 01/22/1991 | US4987125 Antithrombotic activity of the triterpenoids of ilex pubescens and the conversion method of the triterpenoids of ilex pubescens having no antithrombotic activity into the triterpenoids having antithrombotic activity |
| 01/22/1991 | US4987124 Fermentation by other microflora to produce growth-inhibiting metabolites, followed later by administration of antibiotic |
| 01/22/1991 | US4987123 L-alanine and l-glutamine or salts or peptides thereof |
| 01/22/1991 | US4987072 Macrocyclic antibiotics |
| 01/22/1991 | US4986982 Pyroglutamic ester which penetrates skin and is hydrolyzed in situ to moisturizing pyroglutamic acid |
| 01/22/1991 | US4986963 Antiseptic decomposition or neutralization |
| 01/22/1991 | CA2021560A1 Indole derivatives, a process for their preparation and their use in medicaments |
| 01/22/1991 | CA2021525A1 Compounds |
| 01/22/1991 | CA2021042A1 Salts of n ,n -methylene-5,6,7,8-tetrahydrofolic acid |